iRhythm Technologies, Inc. (IRTC) Stock Grade

About iRhythm Technologies, Inc.'s fundamentals

iRhythm Technologies is a medical device company with a $3.7 billion market capitalization that reported 26.2% year-over-year revenue growth, demonstrating strong top-line momentum in its business. Despite this growth, the company operated at a net loss with a -6.0% net margin in its latest annual reporting period. The company does not pay a dividend and generated positive free cash flow despite its accounting losses, indicating that cash generation from operations outpaced the reported net loss. The absence of standard profitability metrics like P/E ratio and return on equity reflects the company's current unprofitable status.